Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Convertible Debt (2020 - 2025)

Collegium Pharmaceutical has reported Convertible Debt over the past 6 years, most recently at $238.2 million for Q4 2025.

  • Quarterly results put Convertible Debt at $238.2 million for Q4 2025, changed 0.44% from a year ago — trailing twelve months through Dec 2025 was $238.2 million (changed 0.44% YoY), and the annual figure for FY2025 was $238.2 million, changed 0.44%.
  • Convertible Debt for Q4 2025 was $238.2 million at Collegium Pharmaceutical, roughly flat from $238.0 million in the prior quarter.
  • Over the last five years, Convertible Debt for COLL hit a ceiling of $262.4 million in Q1 2024 and a floor of $26.4 million in Q1 2022.
  • Median Convertible Debt over the past 5 years was $237.0 million (2024), compared with a mean of $198.9 million.
  • Biggest five-year swings in Convertible Debt: plummeted 81.08% in 2022 and later surged 891.35% in 2023.
  • Collegium Pharmaceutical's Convertible Debt stood at $140.0 million in 2021, then grew by 0.65% to $140.9 million in 2022, then skyrocketed by 86.07% to $262.1 million in 2023, then decreased by 9.52% to $237.2 million in 2024, then grew by 0.44% to $238.2 million in 2025.
  • The last three reported values for Convertible Debt were $238.2 million (Q4 2025), $238.0 million (Q3 2025), and $237.7 million (Q2 2025) per Business Quant data.